HOME > TOP STORIES
TOP STORIES
-
BUSINESS Chugai Lifts Shipment Curbs for Edirol, Easing Active Vitamin D3 Shortages
September 13, 2021
-
REGULATORY Causal Link between Deaths and Recalled Batch of Moderna Jab “Indeterminable”
September 13, 2021
-
REGULATORY Japan Should Arrange Boosters Immediately, Mix-and-Match Doses Too: LDP
September 10, 2021
-
BUSINESS Follow-On AGs Gaining Ground with 10 Launches in 2 Years, More Expected amid Generic Quality Concerns
September 9, 2021
-
BUSINESS MSD Leading in Oral COVID-19 Drug Race in Japan, Trailed by Pfizer; Shionogi Top Domestic Player
September 8, 2021
-
REGULATORY Japan Strikes Deal for 150 Million Novavax Vaccine Doses, Supply Could Start Early Next Year
September 7, 2021
-
BUSINESS Takeda Faces New Problem on Leuplin, System Glitch Cripples Supply of 1, 3-Month Products
September 7, 2021
-
BUSINESS GSK Files COVID-19 Antibody Drug Sotrovimab in Japan
September 7, 2021
-
BUSINESS Japan Pharma Officials Relieved by Exit of Suga, Hardliner on Industry
September 6, 2021
-
REGULATORY Entresto Clears MHLW Panel with Strings Attached, It’s Not a 1st Choice Drug
September 6, 2021
-
BUSINESS Ono Chief, Honjo Remain Divided over Opdivo Royalty in Direct Face-Off
September 3, 2021
-
REGULATORY Nationwide On-Site Inspections Identify GMP Issues at 9 Generic Plants: MHLW
September 3, 2021
-
BUSINESS Takeda Recalling Suspended Batches of Moderna Jabs in Japan; Administrative Action Possible
September 2, 2021
-
REGULATORY MHLW Group Launches Study for Post-Marketing Safety Measures to Boost Global Harmonization, Efficiency
September 1, 2021
-
REGULATORY MHLW Panel Shelves Decision on Entresto’s Hypertension Use, Clears Otsuka’s Eczema Med and More
August 31, 2021
-
REGULATORY MHLW Discussing Mandatory Reporting System for Unstable Drug Supplies
August 30, 2021
-
BUSINESS Medical Societies Issue Joint Statement in Face of Possible Stockout of Abraxane, Calling for Continued Treatment
August 30, 2021
-
BUSINESS Nippon Shinyaku Aims to Maximize Value of Viltepso, Double Sales, Operating Profits in 10 Years: President
August 27, 2021
-
BUSINESS Chugai to File Antibody Cocktail for COVID-19 Prevention among Close Contact Individuals
August 27, 2021
-
REGULATORY Japan Approves Forxiga for CKD, Rinvoq’s Atopic Dermatitis Use and More
August 26, 2021
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
